bioRxivBioinformaticsPreprint
Prediction of Multi peptides Vaccination from VP10,VP21, VP51 against Reverse Transcriptase Human immunodeficiency Viruses Using Immuno-informatics Approach
Safa Ahmad Almostafa, Ienas Ibrahim mohmed, Habab Abd elmoneim Siddig, Sahar Obi Abd AlbagiiD, Nadir Musa Khalil AbuzeidiD
Abstract
The human immunodeficiency virus-(HIV) is group of the genus Lentivirus within the family of Retroviridae, subfamily Ortho retrovirinae. Based on genetic characteristics and differences in the viral antigens, HIV is classified into the types 1 and 2 (HIV-1, HIV-2). HIV is identical single - stranded RNA molecule that are enclosed within the core of the virus particle proteins, the genome of the HIV Provirus, also known as DNA, is generated by the Protease against reverse transcriptase RNA genome into DNA, degradation of the RNA and integration of the double - stranded HIV DNA into the human genome. The aim of this study is to determine antigenic peptides from p10, p21, and p51 proteins that can be used for multiple peptide vaccine design using In-Silico study. A total of 73 sequences of three proteins were obtained from NCBI and subjected to multiple sequence alignments using CLUSTALW tool to determine conserved regions. Immune Epitope Data Base tools were used to determine B cell epitopes, these tools are Bepipred Linear B cell epitopes prediction, surface accessibility and antigenicity prediction. Epitope binding to MHC class I and class II and their population coverage were also determined using IEDB software. The analysis results are as follow, for B cell binding from p10 (708QGYSP712), from p21 (704QGYSP708, 73CVPTDPNPQ81) and (346"FKNL349) from p51. All these peptides have high score in Linear B cell epitopes prediction, surface accessibility and antigenicity prediction. On another hand peptides that reacted to MHC class I were (47EANTTLFCA55, 53FCASDAKAY61, 55,ASDAKAYET63) form p10,(38YYGVPVWKE46, 10PQEVFLVNV18 and 29AAGSTMGAA37) from p21 and (63"EWEFVNTPP71, 70PPLVKLWYQ78 and 79EKEPIVGA87) from p51 protein respectively. It worth noting that the peptides (119IISLWDQSL127, 108CVKLTPLCV116) from p10, (38YYGVPVWKE46, 20LLQYWSQEL34, 16FNMWKNNMV30) from p21 and (7WKGSPAIFQ21, 11WEFVNTPPL25 and 58 FLWMGYELH72) protein is also binds to MHC class II with high affinity. All T cell peptides had highest population coverage, and the combined coverage for all peptides in this study was found to be 100%. Using In-Silico studies will ensure less risk of virulence and side effects. Evaluation of antibodies response in animal models is needed to confirm efficacy of these epitopes in inducing protective immune response.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A novel multi-epitope peptide vaccine candidate targeting Hepatitis E virus: an in-silico approach
- Epitope-based peptide vaccine against glycoprotein G of Nipah henipavirus using immunoinformatics approaches
Arwa A. Mohammed, Shaza Wagiealla Shantier, … Mohamed Ahmed Salih Hassan·Journal of Immunology ResearchPeer-reviewed·Jan 1, 2020
- Harnessing Immunoinformatic for HIV-2: Multi-Epitope Vaccine Design Targeting the env Protein (CAA28914.1)
Muhammad Ali, Yasrab Arafat, … Qanbar Abbas·bioRxiv·Jun 6, 2025
- Multi Epitope Vaccine Prediction Against Aichi Virus using Immunoinformatic Approach
Asma Ali Hassan Ali, Sahar Abdeen Abdalla Mohamed, … Mohamed Ahmed Salih Hassan·bioRxiv·Oct 8, 2019
- Virus-Like Particle Based-Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide
A. T. Mogus, L. Liu, … B. Chackerian·bioRxiv·Sep 25, 2020
- Mpox Vaccine Design Through Immunoinformatics and Computational Epitope Prediction
Sebastián Rivera-Orellana, José Rubén Ramírez-Iglesias, … Andrés López‐Cortés·bioRxiv·Nov 5, 2024